
The Competition and Markets Authority (CMA) has signed a new framework with 5 of its international counterpart competition authorities to improve co-operation on investigations.
The Multilateral Mutual Assistance and Cooperation Framework for Competition Authorities (MMAC) was signed Tuesday, September 2, by Andrea Coscelli, Chief Executive Officer of the Competition and Markets Authority (CMA) and counterparts in Australia, Canada, New Zealand, and the United States, marking a new chapter in inter-agency cooperation to address cross-border anti-competitive activity in an increasingly global economy.
Along with the Australian Competition and Consumer Commission, the New Zealand Commerce Commission, Competition Bureau Canada, the United States Department of Justice, and the United States Federal Trade Commission, the CMA hopes that this ambitious agreement will be the first step to bolstering cooperation between these bodies to assist competition investigations.
The new multinational framework includes a memorandum of understanding focused on reinforcing and improving existing cooperation and coordination on investigations. It also contains a model agreement to support the development of individual arrangements among the participants that may include the exchange of case information and assistance in individual competition investigations, to the extent permitted by respective national laws.
Andrea Coscelli, Chief Executive Officer of the Competition and Markets Authority, said, “I am very pleased to launch this new framework alongside our international counterparts from Australia, Canada, New Zealand and the United States. I hope it will form the basis for future collaborative agreements to address anti-competitive practices that affect us all.”
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas